Ratings by Ladenburg Thalmann (Matthew Kaplan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/31/2024 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 8/1/2024 | United Therapeutics Corp. | UTHR | Downgrade | Neutral (Buy) |
313.29 (478.16) |
52.63% | Details | |
| 7/3/2024 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2024 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2024 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Neutral (Buy) |
7.75 (1.82) |
-76.52% | Details | |
| 8/3/2023 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Reata Pharmaceuticals | RETA | Downgrade | Neutral (Buy) |
167.19 (172.36) |
3.09% | Details | |
| 6/29/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2023 | Athenex | ATNX | Downgrade | Neutral (Buy) |
1.26 (0.20) |
-84.13% | Details | |
| 11/11/2022 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2022 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2022 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
5.03 (36.03) |
616.3% | Details | |
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | Antares Pharma | ATRS | Downgrade | Neutral (Buy) |
5.58 (5.59) |
0.18% | Details | |
| 3/24/2022 | Reneo Pharmaceuticals | RPHM | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2022 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Redhill Biopharma | RDHL | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Ardelyx, Inc | ARDX | Upgrade | Buy (Neutral) |
1.14 (6.19) |
442.98% | Details | |
| 11/22/2021 | Reneo Pharmaceuticals | RPHM | New Coverage | Buy (N/A) |
7.99 (1.82) |
-77.22% | Details | |
| 10/14/2021 | Ardelyx, Inc | ARDX | Downgrade | Neutral (Buy) |
1.09 (6.19) |
467.89% | Details | |
| 8/10/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2021 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2021 | Eledon Pharamceuticals | ELDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2021 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2021 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | Millendo Therapeutics Inc. | MLND | Downgrade | Neutral (Buy) |
1.69 (1.06) |
-37.28% | Details | |
| 12/11/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2020 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Millendo Therapeutics Inc. | MLND | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2020 | Millendo Therapeutics Inc. | MLND | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2020 | Redhill Biopharma | RDHL | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2020 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2020 | Protara Therapeutics | TARA | New Coverage | Buy (N/A) |
28.34 (5.90) |
-79.18% | Details | |
| 12/17/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Anchiano Therapeutics | ANCN | Downgrade | Neutral (Buy) |
1.92 (4.71) |
145.31% | Details | |
| 10/21/2019 | Redhill Biopharma | RDHL | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2019 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2019 | Dova Pharmaceuticals Inc | DOVA | Downgrade | Neutral (Buy) |
28.23 (28.04) |
-0.67% | Details | |
| 9/17/2019 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2019 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2019 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Neutral) |
79.53 (478.16) |
501.23% | Details | |
| 7/22/2019 | Pluristem Therapeutics | PSTI | New Coverage | Buy (N/A) |
0.60 (1.00) |
66.67% | Details | |
| 6/14/2019 | Avadel Pharmaceuticals | AVDL | Upgrade | Buy (Neutral) |
3.04 (21.64) |
611.84% | Details | |
| 4/23/2019 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
16.29 (0.84) |
-94.84% | Details | |
| 4/2/2019 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | BioDelivery Sciences International | BDSI | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2019 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/8/2019 | Avadel Pharmaceuticals | AVDL | Downgrade | Neutral (Buy) |
3.25 (3.04) |
-6.46% | Details | |
| 1/7/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2019 | Millendo Therapeutics Inc. | MLND | New Coverage | Buy (N/A) |
8.20 (1.06) |
-87.07% | Details | |
| 12/12/2018 | Redhill Biopharma | RDHL | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2018 | Athenex | ATNX | New Coverage | Buy (N/A) |
12.97 (0.20) |
-98.46% | Details | |
| 9/26/2018 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2018 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2018 | Vaccinex | VCNX | New Coverage | Buy (N/A) |
9.99 (1.41) |
-85.89% | Details | |
| 8/17/2018 | Antares Pharma | ATRS | Maintain | Buy (N/A) |
|
Details |
